Abstract
Nearly 11% of youth with Autism Spectrum Disorder (ASD) undergo psychiatric hospitalization, and 65% are treated with psychotropic medication. Here we characterize psychotropic medication usage in subjects enrolled in the Autism Inpatient Collection. Participant psychotropic medication usage rates topped 90% at admission and discharge, though there was a decline at 2-month follow-up. Antipsychotics, ADHD medications, and sleep aids were the most commonly reported classes of medications. The impact of age, gender, and non-verbal IQ on medication usage rates was minimal, though age and IQ may play a role in prescribing practices. Future work is indicated to explore medication usage trends, the impact of clinical factors on medication use rates, and the safety of psychotropic medications in youth with ASD.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 3711-3719 |
| Number of pages | 9 |
| Journal | Journal of Autism and Developmental Disorders |
| Volume | 48 |
| Issue number | 11 |
| DOIs | |
| State | Published - Nov 1 2018 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Developmental and Educational Psychology
Cite this
}
Characterization of Medication Use in a Multicenter Sample of Pediatric Inpatients with Autism Spectrum Disorder. / For The Autism And Developmental Disorders Inpatient Research Collaborative (Addirc).
In: Journal of Autism and Developmental Disorders, Vol. 48, No. 11, 01.11.2018, p. 3711-3719.Research output: Contribution to journal › Article
TY - JOUR
T1 - Characterization of Medication Use in a Multicenter Sample of Pediatric Inpatients with Autism Spectrum Disorder
AU - For The Autism And Developmental Disorders Inpatient Research Collaborative (Addirc)
AU - Wink, Logan K.
AU - Pedapati, Ernest V.
AU - Adams, Ryan
AU - Erickson, Craig A.
AU - Pedersen, Kahsi A.
AU - Morrow, Eric M.
AU - Kaplan, Desmond
AU - Siegel, Matthew
AU - Siegel, Matthew
AU - Erickson, Craig
AU - Gabriels, Robin L.
AU - Kaplan, Desmond
AU - Mazefsky, Carla
AU - Morrow, Eric M.
AU - Righi, Giulia
AU - Santangelo, Susan L.
AU - Wink, Logan
AU - Benevides, Jill
AU - Beresford, Carol
AU - Best, Carrie
AU - Bowen, Katie
AU - Dechant, Briar
AU - Flis, Tom
AU - Gastgeb, Holly
AU - Geer, Angela
AU - Hagopian, Louis
AU - Handen, Benjamin
AU - Klever, Adam
AU - Lubetsky, Martin
AU - MacKenzie, Kristen
AU - Meservy, Zenoa
AU - McGonigle, John
AU - McGuire, Kelly
AU - McNeil, Faith
AU - Montrenes, Joshua
AU - Palka, Tamara
AU - Pedapati, Ernest
AU - Pedersen, Kahsi A.
AU - Peura, Christine
AU - Pierri, Joseph
AU - Rogers, Christie
AU - Rossman, Brad
AU - Ruberg, Jennifer
AU - Sannar, Elise
AU - Small, Cathleen
AU - Stuckey, Nicole
AU - Tylenda, Barbara
AU - Verdi, Mary
AU - Vezzoli, Jessica
AU - Williams, Deanna
PY - 2018/11/1
Y1 - 2018/11/1
N2 - Nearly 11% of youth with Autism Spectrum Disorder (ASD) undergo psychiatric hospitalization, and 65% are treated with psychotropic medication. Here we characterize psychotropic medication usage in subjects enrolled in the Autism Inpatient Collection. Participant psychotropic medication usage rates topped 90% at admission and discharge, though there was a decline at 2-month follow-up. Antipsychotics, ADHD medications, and sleep aids were the most commonly reported classes of medications. The impact of age, gender, and non-verbal IQ on medication usage rates was minimal, though age and IQ may play a role in prescribing practices. Future work is indicated to explore medication usage trends, the impact of clinical factors on medication use rates, and the safety of psychotropic medications in youth with ASD.
AB - Nearly 11% of youth with Autism Spectrum Disorder (ASD) undergo psychiatric hospitalization, and 65% are treated with psychotropic medication. Here we characterize psychotropic medication usage in subjects enrolled in the Autism Inpatient Collection. Participant psychotropic medication usage rates topped 90% at admission and discharge, though there was a decline at 2-month follow-up. Antipsychotics, ADHD medications, and sleep aids were the most commonly reported classes of medications. The impact of age, gender, and non-verbal IQ on medication usage rates was minimal, though age and IQ may play a role in prescribing practices. Future work is indicated to explore medication usage trends, the impact of clinical factors on medication use rates, and the safety of psychotropic medications in youth with ASD.
UR - http://www.scopus.com/inward/record.url?scp=85019543395&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85019543395&partnerID=8YFLogxK
U2 - 10.1007/s10803-017-3153-x
DO - 10.1007/s10803-017-3153-x
M3 - Article
C2 - 28516426
AN - SCOPUS:85019543395
VL - 48
SP - 3711
EP - 3719
JO - Journal of Autism and Developmental Disorders
JF - Journal of Autism and Developmental Disorders
SN - 0162-3257
IS - 11
ER -